On November 14th, 2016, after several miscarriages, Heather and Jesse McKee finally welcomed a beautiful baby girl named Ella Rose. With big brown eyes and a head full of dark brown hair, she was exactly what they had hoped and prayed for. Her big brother, Ethan, was in love at first sight. Ella was growing, as she should, happy and hitting milestones along the way, until over time everything started to feel a little delayed. Ella’s pediatrician was concerned with the fact that she had not hit milestones by her 2-year check-up. Her fine motor skills, along with the inability to stand or walk on her own, prompted testing to be done. Ella was sent for some blood work and saw a neurologist who ordered an MRI. None of her delays could have prepared them for what lay ahead. On Saturday, April 13th, 2019 Heather and Jesse received a call from the doctor herself, stating she needed them to come in on Tuesday to review the results. The doctor was very vague, and just insisted that she wanted to speak to them in person. The results they received that following Tuesday, April 16th, 2019 were results no parent should ever have to hear. They were told that Ella’s scans had been sent to and reviewed by specialists at several hospitals across the country. It was with utmost certainty that they concluded Ella has a form of Leukodystrophy. Leukodystrophies are a group of rare, progressive, metabolic, genetic diseases that affect the brain, spinal cord and often the peripheral nerves. There are 50 different types of leukodystrophies. Each type of leukodystrophy is caused by a specific gene abnormality that leads to abnormal development or destruction of the white matter (myelin sheath) of the brain. There are no cures for leukodystrophies, and cases are highly variable, depending on the type. Because of the rarity of leukodystrophies, there are only a few hospitals in the country that specialize in seeing patients with these diseases. The McKee's next step was to be seen at the Children's Hospital of Philadelphia (9 hours from Charlotte, NC and only 1 of 6 hospitals in the US to treat leukodystrophy) to undergo genetic testing using Ella's blood to determine which specific type of leukodystrophy Ella had. In June of 2019 Ella's doctor's at CHOP confirmed that she has Vanishing White Matter Disease (VWMD). Worldwide there have only been around 300 cases of VWMD and in the United States Ella is just the 10th case with her very specific gene abnormality. This disease mainly affects children and symptoms are highly variable for each case. This disease affects Ella's motor skills, speech, hearing, vision, and swallowing. The disease is progressive meaning Ella's symptoms will get worse over time. Progression of the disease comes quicker if Ella experiences head trauma, infections, or sickness. The typical life expectancy is 5-10 years after diagnosis. There is no cure for Vanishing White Matter Disease. However, in June of 2021 the first ever clinical drug trial for VWMD began in Amsterdam. Unfortunately, Ella was not eligible for this trial because she is not able to walk unassisted. In short, Ella needs a miracle. Since diagnosis the McKee's have been devastated to know the very real possibility of losing their little girl too soon to this disease. However, they have been extremely grateful for the outpouring of love from friends and family. They were also very fortunate to take a Make-a-Wish trip to Disney World in March of 2020. While the family does have medical insurance, medical expenses are still aplenty as Ella has weekly occupational therapies, speech therapies, and physical therapies. This is in addition to adaptive medical equipment like her specialized stroller, gait trainer, and foot braces. The family also travels to the Children's Hospital of Philadelphia for Ella's care. They are seeking support to help pay for these expenses. Also, knowing their time with Ella is limited they are seeking support to do as many things with Ella that they can, especially while she is still able to enjoy the many things life has to offer. Lastly, because of the rarity of the disease, it is very hard to get doctors and pharmaceutical companies to fund clinical trials and it is typically up to the families of patients to fund such research. If enough financial support can be provided there is the possibility for future clinical research to help Ella. As of February 2022, Ella is continuing to make progress with all of her hard work and determination. She is an extremely happy 5-year-old. She loves her brother, parents, dogs (especially her Ruby), cousins, friends, family, the beach, baseball (and watching her big brother play it), all things Disney, all animals, dresses, and doing make-up. The McKees are forever grateful for every single person that has helped them along this journey, and they are not losing hope that a miracle for Ella Rose is possible.  For more updates and to follow Ella's journey, please follow her Facebook page at <a href="https://www.facebook.com/A-Miracle-for-Ella-Rose-1200142453479496/" target="_blank" rel="noreferrer noopener"><a href="https://www.facebook.com/A-Miracle-for-Ella-Rose-1200142453479496/" target="_blank" class="" rel="nofollow noopener noreferrer">https://www.facebook.com/A-Miracle-for-Ella-Rose-1200142453479496/</a></a>  Venmo and PayPal options are also available at that page, for donations.

leighann schoenfeld

Michele Long

Virginia Baker

gary black

Cory Devinney

Laurie Howard

michele taylor

Darlene Knudsen

Cheryl MacDonald

Robin Grim

Randy Eline

harold lowery

Lindsay Foess

Lisa Broadway

Sara Johnson

My Ngo

Melanie DeMauro

laura mahoney

Ronnie Whaley

Ron Whaley

A Miracle for Ella Rose

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

A Miracle for Ella Rose

Still $2,299 to go. Help us build momentum.